We have also reported that, in the Otsuka Long Evans Tokushima Fatty rat (animal model of obesity) and in the SHR/NDmcr-cp animal model of metabolic syndrome, treatment of an SGLT2 inhibitor normalized the dipping pattern of blood pressure in addition to its antihypertensive effects (12, 13). This evidence concerns the gene SLC5A2 and Obesity.